The Semaglutide Market Estimated To Witness Strong Growth Due To High Diabetes Incidence And Government Support For Novel Therapies
The Semaglutide market is estimated to be valued at US$ 2.17 Billion in 2022 and is expected to exhibit a CAGR of 8.71% over the …